← Back to guidelines
Cardiology7 papers

Neonatal bradycardia

Last edited: 4/22/2026

Overview

Neonatal bradycardia refers to a significant decrease in heart rate below the normal range for infants, often associated with potential cerebral desaturation and respiratory changes. It can be triggered by various factors including cord clamping timing and may manifest differently in neonates compared to older children and adults 124.

Diagnosis

  • Key Diagnostic Criteria: Episodes of heart rate below the neonatal threshold (typically <100 bpm) 12.
  • Recommended Tests: Continuous ECG monitoring to detect bradycardia episodes 4.
  • Additional Monitoring: Near-infrared spectroscopy (NIRS) to assess cerebral oxygenation during bradycardia events 1.
  • Respiratory Pattern Analysis: Evaluate respiratory patterns alongside heart rate changes, as bradycardia may not always be associated with apnea 4.
  • Management

  • First-Line Treatments: Address underlying causes such as ensuring adequate oxygenation and ventilation 14.
  • Adjunctive Measures: Consider delayed cord clamping to reduce the risk of bradycardia, especially in vigorous infants 2.
  • Monitoring Tools: Utilize NIRS to guide interventions aimed at preventing cerebral desaturation during bradycardia events 1.
  • Special Populations

  • Pediatric Considerations: Vigorous term and late-preterm infants may have a higher risk of bradycardia with early cord clamping 2.
  • Comorbidities: No specific comorbidities detailed in the abstracts, but vigilance in monitoring is advised for neonates with existing respiratory or cardiovascular instability 4.
  • Key Recommendations

  • Use continuous ECG monitoring to detect neonatal bradycardia episodes and assess associated respiratory changes 4 (Evidence: Moderate).
  • Implement delayed cord clamping (>60 seconds) to potentially reduce the incidence of bradycardia in vigorous newborns 2 (Evidence: Moderate).
  • Incorporate NIRS monitoring to evaluate cerebral oxygenation during bradycardia events to guide timely interventions 1 (Evidence: Moderate).
  • References

    1 Falsaperla R, Leone G, Giallongo A, Giacchi V, Lombardo G, Polizzi A et al.. Near-infrared spectroscopy (NIRS) as a tool to prevent cerebral desaturation in newborns with bradycardia events: A systematic review. Pediatrics and neonatology 2025. link 2 Kc A, Kong SYJ, Haaland SH, Eilevstjønn J, Myklebust H, Bastola RC et al.. Increased risk of bradycardia in vigorous infants receiving early as compared to delayed cord clamping at birth. Journal of perinatology : official journal of the California Perinatal Association 2023. link 3 Milstein S, Buetikofer J, Lesser J, Goldenberg IF, Benditt DG, Gornick C et al.. Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia. Journal of the American College of Cardiology 1989. link90006-5) 4 Smith ML, Milner AD. Bradycardia and associated respiratory changes in neonates. Archives of disease in childhood 1981. link

    Original source

    1. [1]
      Near-infrared spectroscopy (NIRS) as a tool to prevent cerebral desaturation in newborns with bradycardia events: A systematic review.Falsaperla R, Leone G, Giallongo A, Giacchi V, Lombardo G, Polizzi A et al. Pediatrics and neonatology (2025)
    2. [2]
      Increased risk of bradycardia in vigorous infants receiving early as compared to delayed cord clamping at birth.Kc A, Kong SYJ, Haaland SH, Eilevstjønn J, Myklebust H, Bastola RC et al. Journal of perinatology : official journal of the California Perinatal Association (2023)
    3. [3]
      Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia.Milstein S, Buetikofer J, Lesser J, Goldenberg IF, Benditt DG, Gornick C et al. Journal of the American College of Cardiology (1989)
    4. [4]
      Bradycardia and associated respiratory changes in neonates.Smith ML, Milner AD Archives of disease in childhood (1981)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG